R331333

5 trials

Sponsors

Grünenthal GmbH

Conditions

Low back Pain MedDRA version: 9.1 Level: LLT Classification code 10024891 Term: Low back painPain MedDRA version: 14.0 Level: PT Classification code 10033371 Term: Pain System Organ Class: 10018065 - General disorders and administration site conditionsPain due to Osteoarthritis MedDRA version: 9.1 Level: LLT Classification code 10031161 Term: Osteoarthritis

Unknown Phase

An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with uncontrolled severe chronic nociceptive, mixed or neuropathic low back pain taking either WHO Step I or Step II analgesics or no regular analgesics.

Active, not recruitingEUCTR2009-010427-12-GB

Grünenthal GmbHLow back Pain MedDRA version: 9.1 Level: LLT Classification code 10024891 Term: Low back pain

Start: 2009-10-14Target: 180Updated: 2012-03-19

An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with severe chronic pain due to osteoarthritis of the knee taking WHO Step III analgesics but showing a lack of tolerability.

Active, not recruitingEUCTR2009-010425-39-GB

Grünenthal GmbHPain due to Osteoarthritis MedDRA version: 9.1 Level: LLT Classification code 10031161 Term: Osteoarthritis

Start: 2009-09-23Target: 180Updated: 2012-03-19

An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with uncontrolled severe chronic pain due to osteoarthritis of the knee taking either WHO Step I or Step II analgesics or no regular analgesics.

Active, not recruitingEUCTR2009-010423-58-GB

Grünenthal GmbHPain due to Osteoarthritis MedDRA version: 9.1 Level: LLT Classification code 10031161 Term: Osteoarthritis

Start: 2009-08-28Target: 180Updated: 2012-03-19

An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with severe chronic nociceptive, mixed or neuropathic low back pain taking WHO Step III analgesics but showing a lack of tolerability.

Active, not recruitingEUCTR2009-010428-25-CZ

Grünenthal GmbHLow back Pain MedDRA version: 9.1 Level: LLT Classification code 10024891 Term: Low back pain

Start: 2010-02-15Target: 180Updated: 2012-04-24

A multicenter, open-label trial to assess cognitive and psychomotor performance as surrogate parameters for driving ability under stable long term treatment with tapentadol hydrochloride prolonged-release tablets in subjects with chronic low back pain or osteoarthritis of the knee.

Active, not recruitingEUCTR2009-015397-35-DE

Grünenthal GmbHPain MedDRA version: 14.0 Level: PT Classification code 10033371 Term: Pain System Organ Class: 10018065 - General disorders and administration site conditions

Start: 2010-02-12Updated: 2012-03-19